Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS). - Wikidata - wikimedia - TriplyDB

Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

http://www.wikidata.org/entity/Q33417246

about

Anti-complement-factor H-associated glomerulopathies.A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL

P2860

Q33434103-298DFA14-AEC7-4FE5-96C7-93205CD2025A Q36544938-627166EF-8EC9-4554-88A7-76834589309B

P2860

Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

http://www.wikidata.org/entity/Q33417246

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Autoantibodies to CD59, CD55, ...... lytic uraemic syndrome (aHUS).

@ast

Autoantibodies to CD59, CD55, ...... lytic uraemic syndrome (aHUS).

@en

type

label

Autoantibodies to CD59, CD55, ...... lytic uraemic syndrome (aHUS).

@ast

Autoantibodies to CD59, CD55, ...... lytic uraemic syndrome (aHUS).

@en

prefLabel

Autoantibodies to CD59, CD55, ...... lytic uraemic syndrome (aHUS).

@ast

Autoantibodies to CD59, CD55, ...... lytic uraemic syndrome (aHUS).

@en

P1433

Q33417246-4D7162DF-EFE4-4D64-ABDA-2BA4324651C1

P1476

Q33417246-792A20A2-BF5C-4775-B994-F131E2F9C79F

P2093

Q33417246-000A5300-5589-4B8E-AC68-D0268F4C6376

Q33417246-1C307264-31EB-47CF-A504-8FF66917B6E2

Q33417246-20952292-18E4-41A2-96DF-4B89F45C04AE

Q33417246-352F19CC-9F37-4A34-A06D-F47DE51E07E1

Q33417246-4871383C-CF7B-4FA3-8A24-2D65CAA8C2B1

Q33417246-67393BA3-F6A6-48C2-A0E0-7DC902DC677E

Q33417246-9FB740F8-D36B-468F-9987-0C3C16DEC9FA

Q33417246-ACC7D16E-1194-42A4-B4AC-472650036399

Q33417246-BDA189D0-080B-4F93-921D-062C7C754195

Q33417246-C36ED931-DCC6-4E15-A3F0-CA5AB3572082

P2860

Q33417246-002726C5-7156-4071-A6EE-B52B6BE4B269

Q33417246-0C2B7C9C-A8F9-4B44-A370-EB3126F293F7

Q33417246-1CE8D2D8-0B98-4FB6-B0C4-AAC1093644E9

Q33417246-2207A908-C17D-414D-8358-5F424F01C2D0

Q33417246-27D02C43-8F24-43EE-B2D2-BEDE1C7B051B

Q33417246-29F82F2E-D60A-4323-8A69-1739227931CB

Q33417246-375C4C34-A3EE-4416-AFB2-4A57188D05BA

Q33417246-391500DE-84FF-45CA-B65B-7E4C62BCE9E1

Q33417246-46722618-7B12-48D1-B634-2544BACFBCA9

Q33417246-60EE70FD-8B33-4A99-9B13-A1047EC4E8EE

P304

Q33417246-FE0B178E-5E2B-4CD2-A0F5-1664B832CBCF

P31

Q33417246-6E0E4C18-6C52-4DF6-87B3-67709976EB96

P356

Q33417246-13FF8752-AE7F-4F65-92E6-5947AFB97CED

P433

Q33417246-1ECBC0CF-12AF-4E3F-8E7B-BE4DF9355338

P478

Q33417246-86942480-BFA2-44F0-AB20-0901E2BAF962

P50

Q33417246-56871BAE-963F-497E-BAD2-3AB5E387DCB9

Q33417246-619AD794-EBFD-4031-B29C-74AF92A332C9

Q33417246-86B11663-238D-47B9-8181-8138BC73FF58

P577

Q33417246-0D77D66F-FFBE-4E91-9F6D-0C00C14AD153

P698

Q33417246-94A02A55-AD6B-4295-9C8F-EF4A3E30E6DF

P921

Q33417246-0797CA50-BEDA-4271-A0BF-30B2D39C36FC

P932

Q33417246-C92FD180-D631-4724-9F32-13A1B2428D05

P356

J.MOLIMM.2014.07.017

P1433

Molecular Immunology

P1476

Autoantibodies to CD59, CD55, ...... lytic uraemic syndrome (aHUS).

@en

P2093

Amy-Claire McLoughlin

http://www.w3.org/2001/XMLSchema#string

Arthur Jackson

http://www.w3.org/2001/XMLSchema#string

Catriona E Barker

http://www.w3.org/2001/XMLSchema#string

Emma Wearmouth

http://www.w3.org/2001/XMLSchema#string

Isabel Y Pappworth

http://www.w3.org/2001/XMLSchema#string

John P Atkinson

http://www.w3.org/2001/XMLSchema#string

Karim Bennaceur

http://www.w3.org/2001/XMLSchema#string

Paula Bertram

http://www.w3.org/2001/XMLSchema#string

Rachael Watson

http://www.w3.org/2001/XMLSchema#string

Sophie Ward

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

Familial haemolytic uraemic syndrome and an MCP mutation.

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome.

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.

P304

287-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLIMM.2014.07.017

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Kevin J Marchbank

P577

2014-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25150608

http://www.w3.org/2001/XMLSchema#string

P921

P932

4452024

http://www.w3.org/2001/XMLSchema#string